» Articles » PMID: 31619219

Severe Community-acquired Pneumonia in General Medical Wards: Outcomes and Impact of Initial Antibiotic Selection

Overview
Journal BMC Pulm Med
Publisher Biomed Central
Specialty Pulmonary Medicine
Date 2019 Oct 18
PMID 31619219
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Most international guidelines recommend empirical therapy for community-acquired pneumonia (CAP) to be based on site of care. Some patients with severe CAP are managed in general wards because of limited intensive care unit (ICU) bed or because of unrecognition of the pneumonia severity. Appropriate initial antibiotic treatment for severe CAP outside ICU has not yet been established. This study aimed to determine the prevalence and the impact of initial antibiotic selection on the outcomes of patients with severe CAP who were admitted and managing in general wards.

Methods: This prospective observational study included consecutive patients hospitalized for presumed CAP in general wards over a 1-year period. Severe CAP was identified using the 2007 Infectious Diseases Society of America (IDSA)/American Thoracic Society (ATS) criteria. Initial antibiotic treatment in the first 24 h were collected. The primary outcome was the rate of unfavorable outcome (composite outcome of treatment failure and in-hospital death). The secondary outcome was the number of hospital-free days assessed 30 days after enrollment into the study.

Results: There were 94 patients hospitalized with CAP of which 50 (53.2%) patients were compatible with severe CAP. An etiologic diagnosis was found in 43 (45.8%) patients. The most common pathogens identified in patients with severe CAP were Staphylococcus aureus (28.6%) and Klebsiella pneumoniae (28.6%), followed by Pseudomonas aeruginosa (17.9%). Patients with severe CAP had significantly more positive blood culture than patients with non-severe CAP (24% VS 4.5%; p = .008). Initial antibiotic treatment were discordant with the IDSA/ATS guidelines in 42% of all patients hospitalized with CAP, and 52% of patients with severe CAP. Multivariate analysis revealed that age (OR 1.1, 95% CI 1.01-1.1) and initial antibiotic treatment discordant to guidelines for severe CAP in ICU (OR 4.6, 95% CI 1.3-17.1) were independent risk factors of the unfavorable outcome of patients with severe CAP. Patients with unfavorable outcome had lower number of hospital-free days than patients with favorable outcome (5.2 ± 8 days VS 18 ± 7.1 days; p < .001).

Conclusions: Patients with severe CAP outside ICU should be recognized for appropriate initial antibiotic selection to improve outcomes.

Citing Articles

Prognostic value of the platelet, neutrophil, monocyte, basophil, and eosinophil to lymphocyte ratios in patients with severe community-acquired pneumonia (SCAP).

Cui X, Xie B, Zhu K, Liao Q, Zhou J, Du S Sci Rep. 2024; 14(1):30406.

PMID: 39638829 PMC: 11621349. DOI: 10.1038/s41598-024-80727-1.


Preventive effects of 23-valent pneumococcal polysaccharide vaccine on community-acquired pneumonia hospitalization in older individuals in China: A case-control study.

Liu N, Wang L, Luan L, Wang H Hum Vaccin Immunother. 2024; 20(1):2420450.

PMID: 39610023 PMC: 11610549. DOI: 10.1080/21645515.2024.2420450.


Recovery Time From Severe Community Acquired Pneumonia and Risk Factors Among Pediatrics, Ethiopia: A Retrospective Follow-Up Study.

Wake A Glob Pediatr Health. 2024; 11:2333794X241256860.

PMID: 38882550 PMC: 11177736. DOI: 10.1177/2333794X241256860.


Elucidation of the needs for telecritical care services in Japan: a qualitative study.

Morimoto M, Nawa N, Okada E, Itsui Y, Kashimada A, Yamamoto K BMJ Open. 2023; 13(11):e072065.

PMID: 37984942 PMC: 10660656. DOI: 10.1136/bmjopen-2023-072065.


[Construction of a predictive model for performing bronchoalveolar lavage in children with pneumonia and pulmonary consolidation].

Wang S, Zhang W, Wan Y Zhongguo Dang Dai Er Ke Za Zhi. 2023; 25(10):1052-1058.

PMID: 37905763 PMC: 10621064. DOI: 10.7499/j.issn.1008-8830.2305113.


References
1.
Chalmers J, Taylor J, Mandal P, Choudhury G, Singanayagam A, Akram A . Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care. Clin Infect Dis. 2011; 53(6):503-11. DOI: 10.1093/cid/cir463. View

2.
Baddour L, Yu V, Klugman K, Feldman C, Ortqvist A, Rello J . Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med. 2004; 170(4):440-4. DOI: 10.1164/rccm.200311-1578OC. View

3.
Menendez R, Torres A, Aspa J, Capelastegui A, Prat C, Rodriguez de Castro F . [Community acquired pneumonia. New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR)]. Arch Bronconeumol. 2010; 46(10):543-58. DOI: 10.1016/j.arbres.2010.06.014. View

4.
Torres A, Blasi F, Peetermans W, Viegi G, Welte T . The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis. 2014; 33(7):1065-79. PMC: 4042014. DOI: 10.1007/s10096-014-2067-1. View

5.
Sinuff T, Kahnamoui K, Cook D, Luce J, Levy M . Rationing critical care beds: a systematic review. Crit Care Med. 2004; 32(7):1588-97. DOI: 10.1097/01.ccm.0000130175.38521.9f. View